Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylphenidate for Cognitive Abilities in Bipolar Disorder
NCT02020200Unknown
- Sponsor
- Shalvata Mental Health Center
- Start
- Jan 2014
- Primary completion
- Dec 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of methylphenidate in bipolar disorder (BD), sponsored by Shalvata Mental Health Center. Primary endpoint: Cognitive function at 4 hours. Status: unknown.
02
Drugs
methylphenidate
03
Conditions
bipolar disorder (BD)
Beyond the preview
Go deeper on NCT02020200.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02020200.